Corrigendum to Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): Outcomes of a propensity score-matched analysis [Ann Oncol, 6 (2013) 1543-1548] doi: 10.1093/annonc/mdt026);Stage I-II non-small-cell lung cancer treated usingeither stereotactic ablative radiotherapy (SABR) orlobectomy by video-assisted thoracoscopic surgery(VATS): Outcomes of a propensity score-matchedanalysis

Annals of Oncology

Volumn 24, Issue 6, 2013, Pages 1543-1548

  Verstegen, N E ^a   Oosterhuis, J W A ^a   Palma, D A ^b   Rodrigues, G ^b   Lagerwaard, F J ^a   van der Elst, A ^c   Mollema, R ^d   van Tets, W F ^e   Warner, A ^b   Joosten, J J A ^f   Amir, M I ^g   Haasbeek, C J A ^a   Smit, E F ^a   Slotman, B J ^a   Senan, S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c Infection and Immunology   (Netherlands)

^d Location Alkmaar   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f Westfries Gasthuis ^*  (Netherlands)

^g Waterland Hospital   (Netherlands)

Author keywords

Early stage; Lobectomy; Non small cell lung cancer; SABR; Stereotactic radiotherapy; VATS

Indexed keywords

AGE; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CHARLSON COMORBIDITY INDEX; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; HUMAN TISSUE; LOBECTOMY; LOCAL RECURRENCE FREE SURVIVAL; LUNG FUNCTION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; RETROSPECTIVE STUDY; STEREOTACTIC ABLATIVE RADIOTHERAPY; VIDEO ASSISTED THORACOSCOPIC SURGERY;

EID: 84878448602     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt347     Document Type: Erratum

References (34)

1. Jemal A, Bray F, Center MM et al. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Ettinger DS, Kris MG. NCCN: non-small cell lung cancer. Cancer Control 2001; 8: 22-31.
3. Palma D, Visser O, Lagerwaard FJ et al. Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis. J Clin Oncol 2010; 28: 5153-5159.
4. Yamamoto K, Ohsumi A, Kojima F et al. Long-term survival after video-assisted thoracic surgery lobectomy for primary lung cancer. Ann Thorac Surg 2010; 89: 353-359.
5. Ilonen IK, Rasanen JV, Knuuttila A et al. Anatomic thoracoscopic lung resection for non-small cell lung cancer in stage I is associated with less morbidity and shorter hospitalization than thoracotomy. Acta Oncol 2011; 50: 1126-1132.
6. Palma DA, Senan S. Improving outcomes for high-risk patients with early-stage non-small-cell lung cancer: insights from population-based data and the role of stereotactic ablative radiotherapy. Clin Lung Cancer 2012. doi: 10.1016/j.cllc.2012.06.005
7. Chi A, Liao Z, Nguyen NP et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol 2010; 94: 1-11.
8. Verstegen NE, Lagerwaard FJ, Haasbeek CJ et al. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother Oncol 2011; 101: 250-254.
9. Onishi H, Shirato H, Nagata Y et al. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 2011; 81: 1352-1358.
10. Lagerwaard FJ, Verstegen NE, Haasbeek CJ et al. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2012; 83: 348-353.
11. Palma D, Visser O, Lagerwaard FJ et al. Treatment of stage I NSCLC in elderly patients: a population-based matched-pair comparison of stereotactic radiotherapy versus surgery. Radiother Oncol 2011; 101: 240-244.
12. Belgers EH, Siebenga J, Bosch AM et al. Complete video-assisted thoracoscopic surgery lobectomy and its learning curve. A single center study introducing the technique in The Netherlands. Interact Cardiovasc Thorac Surg 2010; 10: 176-180.
13. International Union Against Cancer. TNM Classification of Malignant Tumours, 7th edition. New York, NY: Wiley-Blackwell 2009.
14. De Leyn P, Lardinois D, Van Schil PE et al. ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer. Eur J Cardiothorac Surg 2007; 32: 1-8.
15. Hurkmans CW, Cuijpers JP, Lagerwaard FJ et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study. Radiat Oncol 2009; 4: 1.
16. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
17. Herder GJ, van Tinterent TH, Golding RP et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18Ffluorodeoxyglucose positron emission tomography. Chest 2005; 128: 2490-2496.
18. Austin P. A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality. Multivariate Behav Res 2011; 46: 119-151.
19. Common Terminology Criteria for Adverse Events version 4.0. http://ctep.cancer. gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40 (22 February 2012, date last accessed).
20. Grills IS, Mangona VS, Welsh R et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 2010; 28: 928-935.
21. Crabtree TD, Denlinger CE, Meyers BF et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J Thorac Cardiovasc Surg 2010; 140: 377-386.
22. Felip E, Rosell R, Maestre JA et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer. J Clin Oncol 2010; 28: 3138-3145.
23. Gould MK, Fletcher J, Iannettoni MD et al. Evaluation of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007; 132: 108S-1030S.
24. Baumann P, Nyman J, Hoyer M et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol 2009; 27: 3290-3296.
25. Sawada S, Yamashita M, Komori E et al. Evaluation of resected tumors that were not diagnosed histologically but were suspected of lung cancer preoperatively. J Thoracic Oncol 2007; 2; S422.
26. van Tinteren H, Hoekstra OS, Smit EF et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected nonsmall-cell lung cancer: the PLUS multicentre randomised trial. Lancet 2002; 359: 1388-1393.
27. Schaue D, Ratikan JA, Iwamoto KS et al. Maximizing tumor immunity with fractionated radiation. Int J Radiat Oncol Biol Phys 2012; 83: 1306-1310.
28. Lee Y, Auh SL, Wang Y et al. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009; 114: 589-595.
29. Timmerman R, Bastasch M, Saha D et al. Stereotactic body radiation therapy: normal tissue and tumor control effects with large dose per fraction. Front Radiat Ther Oncol 2011; 43: 382-394.
30. O'Leary DP, Wang JH, Cotter TG et al. Less stress, more success? Oncological implications of surgery-induced oxidative stress. Gut 2011. doi: 10.1136/gutjnl-2011-300948.
31. Saynak M, Veeramachaneni NK, Hubbs JL et al. Local failure after complete resection of N0-1 non-small cell lung cancer. Lung Cancer 2011; 71: 156-165.
32. Osarogiagbon RU, Allen JW, Farooq A et al. Outcome of surgical resection for pathologic N0 and Nx non-small cell lung cancer. J Thorac Oncol 2010; 5: 191-196.
33. Hung JJ, Jeng WJ, Hsu WH et al. Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer. J Thorac Oncol 2012; 7: 397-405.
34. Zhao H, Bu L, Yang F et al. Video-assisted thoracoscopic surgery lobectomy for lung cancer: the learning curve. World J Surg 2010; 34: 2368-2372.